[{"address1": "3060 Pegasus Park Drive", "address2": "Building 6", "city": "Dallas", "state": "TX", "zip": "75247", "country": "United States", "phone": "310 618 6994", "website": "https://www.fortebiorx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Dr. Paul A.  Wagner Ph.D.", "age": 54, "title": "CEO, President & Chairman", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1030848, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Antony A. Riley CPA", "age": 57, "title": "Chief Financial Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 652090, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Barbara K. Finck M.D.", "age": 77, "title": "Chief Medical Clinician & Director", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 488057, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Roenfeldt", "title": "Chief Operating Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 22.65, "open": 22.68, "dayLow": 21.36, "dayHigh": 23.71, "regularMarketPreviousClose": 22.65, "regularMarketOpen": 22.68, "regularMarketDayLow": 21.36, "regularMarketDayHigh": 23.71, "payoutRatio": 0.0, "beta": 3.254, "forwardPE": -6.1466866, "volume": 211238, "regularMarketVolume": 211238, "averageVolume": 103479, "averageVolume10days": 67390, "averageDailyVolume10Day": 67390, "bid": 20.84, "ask": 22.72, "bidSize": 1, "askSize": 1, "marketCap": 267700608, "fiftyTwoWeekLow": 4.9, "fiftyTwoWeekHigh": 25.97, "allTimeHigh": 6732.375, "allTimeLow": 4.11, "fiftyDayAverage": 15.3386, "twoHundredDayAverage": 11.078365, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 174286608, "profitMargins": 0.0, "floatShares": 6565492, "sharesOutstanding": 12526935, "sharesShort": 129120, "sharesShortPriorMonth": 472924, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.010299999, "heldPercentInsiders": 0.04935, "heldPercentInstitutions": 0.83789, "shortRatio": 1.15, "shortPercentOfFloat": 0.012200001, "impliedSharesOutstanding": 12526935, "bookValue": 4.717, "priceToBook": 4.530422, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -51742000, "trailingEps": -0.08, "forwardEps": -3.47667, "lastSplitFactor": "1:25", "lastSplitDate": 1724803200, "enterpriseToEbitda": -3.265, "52WeekChange": 0.19462025, "SandP52WeekChange": 0.13613915, "quoteType": "EQUITY", "currentPrice": 21.37, "targetHighPrice": 75.0, "targetLowPrice": 19.0, "targetMeanPrice": 54.8, "targetMedianPrice": 61.0, "recommendationKey": "none", "numberOfAnalystOpinions": 5, "totalCash": 93414000, "totalCashPerShare": 7.457, "ebitda": -53382000, "totalDebt": 0, "quickRatio": 7.231, "currentRatio": 7.344, "returnOnAssets": -0.58066005, "returnOnEquity": -1.10722, "freeCashflow": -24480124, "operatingCashflow": -44425000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "FBRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Forte Biosciences, Inc.", "longName": "Forte Biosciences, Inc.", "regularMarketChangePercent": -5.65121, "regularMarketPrice": 21.37, "corporateActions": [], "postMarketTime": 1765586673, "regularMarketTime": 1765573202, "exchange": "NCM", "messageBoardId": "finmb_594626683", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "dividendDate": 1592265600, "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.08, "epsForward": -3.47667, "epsCurrentYear": -4.316, "priceEpsCurrentYear": -4.951344, "fiftyDayAverageChange": 6.0314007, "fiftyDayAverageChangePercent": 0.39321715, "twoHundredDayAverageChange": 10.2916355, "twoHundredDayAverageChangePercent": 0.928985, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1492090200000, "postMarketChangePercent": 2.2461371, "postMarketPrice": 21.85, "postMarketChange": 0.47999954, "regularMarketChange": -1.28, "regularMarketDayRange": "21.36 - 23.71", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 103479, "fiftyTwoWeekLowChange": 16.470001, "fiftyTwoWeekLowChangePercent": 3.3612247, "fiftyTwoWeekRange": "4.9 - 25.97", "fiftyTwoWeekHighChange": -4.5999985, "fiftyTwoWeekHighChangePercent": -0.1771274, "fiftyTwoWeekChangePercent": 19.462025, "marketState": "CLOSED", "displayName": "Forte Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-12-13"}]